| Host: |
Rabbit |
| Applications: |
IHC/WB |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-tRNA N3-methylcytidine methyltransferase METTL8, mitochondrial-methylcytidine methyltransferase METTL8 (C-Term) is suitable for use in Immunohistochemistry and Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000IHC 1:50-200 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
METTL8 |
| Gene ID: |
79828 |
| Uniprot ID: |
METL8_HUMAN |
| Immunogen Region: |
C-Term |
| Specificity: |
This antibody detects endogenous levels of METL8 at Human, Mouse |
| Immunogen: |
Synthesized peptide derived from human C-ternal METL8 |
| Protein Name | Trna N(3-Methylcytidine Methyltransferase Mettl8 - MitochondrialMethyltransferase-Like Protein 8Mrna N(3-Methylcytidine Methyltransferase Mettl8 |
| Cellular Localisation | MitochondrionMitochondrial Protein: The Cytoplasmic Or Nuclear Localization Observed By Some Groups Is Either The Result Of An Incorrect Localization Caused By N-Terminal Tagging That Interferes With Mitochondrial TargetingOr Splice Isoforms That Lack The N-Terminal Mitochondrial Transit Sequence |
| Alternative Antibody Names | Anti-Trna N(3-Methylcytidine Methyltransferase Mettl8 - Mitochondrial antibodyAnti-Methyltransferase-Like Protein 8 antibodyAnti-Mrna N(3-Methylcytidine Methyltransferase Mettl8 antibodyAnti-METTL8 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
